Accession Number: | 0001683168-22-002000 |
Date: | 2022-03-24 |
Issuer: | XENETIC BIOSCIENCES, INC. (XBIO) |
Original Submission Date: |
EISENBERG JEFFREY F
40 SPEEN STREET, SUITE 102
FRAMINGHAM, MA 01701
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTIONS | 1.12 | 2022-03-24 | deemed execution date | A | 100,000 (a) | 2032-03-24 | common stock 100,000 | $1.12 | 100,000 | direct |
ID | footnote |
---|---|
f1 | the shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of march 24, 2022; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on june 24, 2023 and ending on march 24, 2025. |